Fortress Biotech transformed its balance sheet by selling a Priority Review Voucher for $205 million, netting $159 million.

Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $20.5 ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended June 30, 2026 and ...

Q2 2026 Earnings Call July 30, 2026 10:00 AM EDTCompany ParticipantsPatrick Giles Dear - PrincipalStephen Prince ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results ...

Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance Highlights For the three months ended June 30, 2026: Revenues of $678.2 mi ...

Allegheny Health Network strengthened IV compounding safety by adopting automated workflows to reduce variability and enhance dose accuracy.

China product sales recovery continues led by ELUNATE® and SULANDA® with over 40% growth each — — FRUZAQLA® ex-US sales driving growth – now approved or launched in 41 countries — — Strong progress in ...

Dantrolene sodium 20mg; per vial; lyophilized pwd for IV inj after reconstitution; contains mannitol. In isolated nerve-muscle preparation, dantrolene sodium has been shown to produce relaxation by ...

(NYSE: MO) today reports our 2026 second-quarter and first-half business results and narrows guidance for 2026 ful ...

Implied volatility (IV) is a key metric used by traders to determine options pricing and market forecasts. Gain insight into ...

He has a farmer’s preoccupation with the weather, and lately he’s been keeping an eye on the economic weather as well, ...